Genmab — April 2014
-
men hold nu kæft hvor er det godt - det her har vi ventet på i maaaaange år
-
-
Det er dejligt at den sten nu er faldet

-
EMA overvejer jo stadig bendamustine da de har bedt om yderligere data herom
-
310 er nok lige offensivt nok...
-
i hvert fald til på tirsdag
-
Susie Novis(President. International Myeloma Foundation) har skrevet følgende på sin Twitter: "Daratumumab very promising! Phase 2 trial almost done, stay tuned!" Og senere: "Daratumumab can be used in combinations and patients are showing very good responses!". Spændende.
-
jeg overvejer at købe via GMXAY men holder mig nok væk
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind